• S3 E2 - Marina Baretti, MD – Management of Safety When Using FGFR inhibitors

  • Jun 26 2023
  • Length: 29 mins
  • Podcast

S3 E2 - Marina Baretti, MD – Management of Safety When Using FGFR inhibitors

Listen for free

View show details

  • Summary

  • This is the second episode in our series on cholangiocarcinoma which aims to update clinicians on the latest developments in its diagnosis and management.

    In this episode, Dr. Marina Baretti discusses the safety of fibroblast growth factor receptor (FGFR) inhibitors, drawing from her clinical experience. She details current safety data, and explains what you need to know about the management of their side effects and adverse events.

    For more podcast episodes from Karger please visit karger.com/podcasts.

    This podcast was funded by Taiho Oncology, Inc.  The faculty and publisher are solely responsible for this content. Taiho does not recommend or endorse  the use of its products other than as described in the approved labeling. The content of this site is not medical advice and does not replace independent medical judgment.

     
    Show More Show Less
Show More Show Less

What listeners say about S3 E2 - Marina Baretti, MD – Management of Safety When Using FGFR inhibitors

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available